Humana Inc. (HUM)

Market Cap	27.35B
Revenue (ttm)	120.26B
Net Income (ttm)	1.71B
Shares Out	120.69M
EPS (ttm)	14.16
PE Ratio	16.00
Forward PE	14.89
Dividend	$3.54 (1.56%)
Ex-Dividend Date	Jun 27, 2025

Volume	1,555,376
Open	226.51
Previous Close	224.93
Day's Range	221.00 - 227.69
52-Week Range	212.45 - 406.46
Beta	0.50
Analysts	Hold
Price Target	285.40 (+25.94%)
Earnings Date	Apr 30, 2025

About HUM

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical a...

• Industry: Healthcare Plans
• Sector: Healthcare
• IPO Date: Jan 22, 1993
• Employees: 65,680
• Stock Exchange: NYSE
• Ticker Symbol: HUM
• Website: https://www.humana.com

Financial Performance

In 2024, Humana's revenue was $117.76 billion, an increase of 10.70% compared to the previous year's $106.37 billion. Earnings were $1.21 billion, a decrease of -51.51%.

Analyst Forecast

According to 21 analysts, the average rating for HUM stock is "Hold." The 12-month stock price forecast is $285.4, which is an increase of 25.94% from the latest price.

Price Target

$285.4

(25.94% upside)

Analyst Consensus: Hold